The apolipoprotein E ε4 allele causes a faster decline of cognitive performances in Down's syndrome subjects

Journal of the Neurological Sciences

Volumn 145, Issue 1, 1997, Pages 87-91

  Del Bo, R ^a   Comi, G P ^b   Bresolin, N ^b   Castelli, E ^a   Conti, E ^a   Degiuli, A ^a   Ausenda, C D ^b   Scarlato, G ^b  

^a SCIENTIFIC INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Alzheimer's disease; amyloid; apoliprotein E4; cognitive ability; Down's syndrome; mental retardation

Indexed keywords

APOLIPOPROTEIN E; AMYLOID; APOLIPOPROTEIN E4;

ADOLESCENT; ADULT; ALLELE 4; ALZHEIMER DISEASE; ARTICLE; CHILD; COGNITION; CONTROLLED STUDY; DNA DETERMINATION; DOWN SYNDROME; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGY; PRIORITY JOURNAL; ALLELE; COGNITIVE DEFECT; DISEASE COURSE; GENETICS; GENOTYPE; INFANT; MUTATION; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PHYSIOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ADULT; ALLELES; AMYLOID; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CHILD; CHILD, PRESCHOOL; COGNITION DISORDERS; DISEASE PROGRESSION; DOWN SYNDROME; GENOTYPE; HUMANS; INFANT; MUTATION; NEUROPSYCHOLOGICAL TESTS;

EID: 0030615226     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(96)00249-3     Document Type: Article

References (25)

1. Becker, L.E., Mito, T., Takashima, S., Onodera, K., Friend, W.C. (1993) Association of phenotypic abnormalities of Down syndrome with an imbalance of genes on chromosome 21. APMIS, Suppl. 40, 101: 57-70.
2. Carlsson, J., Armstrong, V.W., Reibert, H., Felgenhauer, K., Seidel, D. (1991) Clinical relevance of quantification of apolipoprotein E in cerebrospinal fluid. Clin. Chim. Acta, 196: 167-175.
3. Corder, E.H., Saunders, A.M., Strittmatter, W.J., Schmechel, D.E., Gaskell, P.C., Small, G.W., Roses, A.D., Haines, J.L., Pericak-Vance, M.A. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science, 261: 921-923.
4. Dickinson, M.J., Singh, I. (1993) Down's syndrome, dementia, and superoxide dismutase. British J. Psychiatry, 162: 811-817.
5. Han, S.-H., Einstein, G., Weisgraber, K.H., Weisgraber, K.H., Strittmatter, W.J., Saunders, A.M., Pericak-Vance, M., Roses, A.D., Schmechel, D.E. (1994) Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study. J. Neuropathol. Exp. Neurol., 53: 535-544.
6. Hof, P.R., Bouras, C., Perl, D.P., Sparks, D.L., Mehta, N., Morrison, J.H. (1995) Age-related distribution of neuropathologic changes in the cerebral cortex of patients with Down's syndrome. Arch. Neurol., 52: 379-391.
7. Holland, A.J., Oliver, C. (1995) Down's syndrome and the links with Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry, 59: 111-114.
8. Hixson I.E., Vernier D.T. (1990) Restricion isotyping of human apolipoprotein E by gene amplification by amplification and cleavage with HhaI. J. Lipid Res.
9. Hyman, B.T., West, H.L., Rebeck, G.W., Lai, F., Mann, D.M.A. (1995) Neuropathological changes in Down's syndrome hippocampal formation. Arch. Neurol., 52: 373-378.
10. Mann, D.M.A., Yuonis, N., Jones, D., Stoddart, R.W. (1992) The time course of pathological events in Down's syndrome with particular reference to the involvement of microglial cells and deposits of b/A4. Neurodegeneration, 1: 201-215.
11. Namba, Y., Tomonaga, M., Kawasaki, H., Otomo, E., Ikeda, K. (1991) Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res., 541: 163-166.
12. Rogaev, E.I., Sherrington, R., Rogaeva, E.A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., Mar, L., Sorbi, S., Nacmias, B., Piacentini, S., Amaducci, L., Chumakov, I., Cohen, D., Lannfelt, L., Fraser, P.E., Rommens, J.M., St George-Hyslop, P.H. (1995) Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene. Nature, 376: 775-778.
13. Roses, A.D. (1994) Apolipoprotein E affects the rate of Alzheimer disease expression: β-amyloid burden is a secondary consequence dependent on APOE genotype and duration of disease. J. Neuropathol. Exp. Neurol., 53: 429-437.
14. Royston, M.C., Mann, D., Pickering-Brown, S., Owen, F., Perry R., Raghavan, R., Khin-Nu, C., Tyrer, S., Day, K., Crook, R. (1994) Apolipoprotein E epsilon 2 allele promotes longevity and protects patients with Down's syndrome from dementia. Neuroreport, 5: 2583-2585.
15. Saunders, A.M., Strittmatter, W.J., Schmechel, D., George-Hyslop, St., Pericak-Vance, M.A., Joo, S.H., Rosi, B.L., Gusella, J.F., Crapper-MacLachlan, D.R., Alberts, M.J., Hulette, C., Crain, B., Goldgaber, D., Roses, A.D. (1993) Association of apolipoprotein E allele e4 with late-onset familial and sporadic Alzheimer's disease. Neurology, 43: 1467-1472.
16. Schmechel, D.E., Saunders, A.M., Strittmatter, W.J., Crain, B.J., Hulette, C.M., Joo, S.H., Pericak-Vance, M.A., Goldgaber, D., Roses, A.D. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. USA, 90: 9649-9653.
17. Selkoe, D.J. (1994) Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol., 53: 438-447.
18. Sherrington, R., Rogaev, E.I., Liang, Y., Rogaeva, E.A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., Tsuda, T., Mar, L., Foncin, J.-F., Bruni, A.C., Montesi, M.P., Sorbi, S., Rainero, I., Pinessi, L., Nee, L., Chumakov, I., Pollen, D., Brookes, A., Sanseau, P., Polinsky, R.J., Wasco, W., Da Silva, H.A.R., Haines, J.L., Pericak-Vance, M.A., Tanzi, R.E., Roses, A.D., Fraser, P.E., Rommens, J.M., St George-Hyslop, P.H. (1995) Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease. Nature, 375: 754-760.
19. Tsai, M.-S., Tangalos, E.G., Petersen, R.C., Smith, G.E., Schaid, D.J., Kokmen, E., Ivnik, R.J., Thibodeau, S.N. (1994) Apolipoprotein E: risk factor for Alzheimer's disease. Am. J. Hum. Genet., 54: 643-649.
20. Van Broeckhoven, C.L. (1995) Molecular genetics of Alzheimer disease: identification of genes and gene mutations. Eur. Neurol., 35: 8-19.
21. Van Gool, W.A., Evenhuis, H.M., Van Duijn, C.M. (1995) A case-control study of apolipoprotein E genotypes in Alzheimer's disease associated with Down's syndrome. Ann. Neurol., 38: 225-230.
22. Weisgraber, K.H., Roses, A.D., Strittmatter, W.J. (1994) The role of apolipoprotein E in the nervous system. Curr. Opin. Lipidol., 5: 110-116.
23. Wenham, P.R., Price, W.H., Blundell, G. (1991) Apolipoprotein E genotyping by one-stage PCR. Lancet, 337: 1158-1159.
24. Wisniewski, T., Frangione, B. (1992) Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid. Neurosci. Lett., 135: 235-238.
25. Wisniewski, T., Morelli, L., Wegiel, J., Levy, E., Wisniewski, H.M., Frangione, B. (1995) The influence of apolipoprotein E isotypes on Alzheimer's disease pathology in 40 cases of Down's syndrome. Ann. Neurol., 37: 136-138.